Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
sabato, ottobre 31
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Merit Medical Systems Inc
MMSI
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$86.24
-7.15
-7.66%
Ult. Agg.: Oct 30, 4:00 PM
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Utili:
I risultati di Q3 2026 sono stati pubblicati in data gio ott 29th, dopo la chiusura del mercato
Conference call:
La conference call più recente è iniziata alle 4:30 PM, 2 giorni fa
Clicca per vedere il webcast
Fusioni e acquisizioni:
Solo Pace, Inc was acquired by Merit Medical Systems (MMSI) on Thursday, October 29, 2026 for $45M
Merit Medical Systems Financials
Merit Medical Systems (MMSI) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
These Analysts Boost Their Forecasts On Merit Medical Systems After Strong Q3 Results
Merit Medical beat Q3 estimates, raised FY2026 EPS guidance, narrowed sales outlook; analysts lifted price targets to $110 and $106.
Avi Kapoor
PRO
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 Est; Narrows FY2026 Sales Guidance from $1.631B-$1.643B to $1.635B-$1.642B vs $1.636B Est
Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.25-$4.35 to $4.33-$4.37 vs $4.30 analyst estimate. Narrows FY2026 sales outlook from $1.631 billion-$1.643 billion to $1.635 billion-$1.642
Benzinga Newsdesk
PRO
Merit Medical Systems Q3 Adj. EPS $1.12 Beats $1.03 Estimate, Sales $416.244M Beat $410.376M Estimate
Merit Medical Systems (NASDAQ:MMSI) reported quarterly earnings of $1.12 per share which beat the analyst consensus estimate of $1.03 by 8.74 percent. This is a 21.74 percent increase over earnings of $0.92 per share
Benzinga Newsdesk
These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results
Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised guidance. Analysts maintain Buy ratings with increased price targets.
Avi Kapoor
PRO
Merit Medical Systems Raises FY2026 Adj EPS Guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 Est; Raises FY2026 Sales Guidance from $1.612B-$1.634B to $1.631B-$1.643B vs $1.620B Est
Merit Medical Systems (NASDAQ:MMSI) raises FY2026 Adj EPS guidance from $4.01-$4.15 to $4.25-$4.35 vs $4.07 analyst estimate. Raises FY2026 sales outlook from $1.612 billion-$1.634 billion to $1.631 billion-$1.643
Benzinga Newsdesk
PRO
Merit Medical Systems Q2 Adj. EPS $1.19 Beats $0.96 Estimate, Sales $418.843M Beat $405.268M Estimate
Benzinga Newsdesk
